PHILADELPHIA — Approximately 20 percent of patients admitted to the hospital with chronic obstructive pulmonary disease (COPD) are readmitted within 30 days, and it’s estimated that 10 to 50 percent of these return trips may be preventable. In just 90 days, a multidisciplinary team from Penn Medicine has shown that an automated texting program to monitor COPD patient status following discharge may have helped prevent three readmissions and intervened with one life-saving hospitalization. The platform is a promising avenue for a cost-effective way to engage these patients, reduce readmissions, and save lives.
Results from the BreatheBetterTogether pilot program and others will be presented at Innovation Accelerator Pitch Day on Monday, April 16, during which four teams of health care professionals with ideas to transform patient care will pitch pilot results – targeting both top drivers of readmissions and some of the most vulnerable patient populations – will present results of their pilot programs for the chance to secure increased funding to further test and scale promising solutions.
Past Innovation Accelerator grant winners IMPaCT (improving health in high-risk populations through the effective use of community health workers) and Heart Safe Motherhood (engaging patients in text-based remote monitoring to improve outcomes and reduce cost) will also present on how they’ve successfully brought their innovations to scale since receiving their initial seed funding.
Join us to meet the teams, learn about the problems they're trying to solve, and the creative solutions they're exploring to dramatically impact value, outcomes and patient experience. Click here for descriptions of all of the projects that will be presented.
WHERE:
Jordan Medical Education Center
Law Auditorium, 5th Floor
3400 Civic Center Boulevard
Philadelphia, PA 19104
**Press officers will be stationed in the lobby of the Perelman Center for Advanced Medicine to escort you to the Jordan Medical Education Center**
WHEN:
Monday, April 16, 2017
3:30 p.m. – 5:00 p.m.
WHO:
- Ralph W. Muller, chief executive officer of the University of Pennsylvania Health System
- Kevin Mahoney, executive vice president and chief administrative officer of the University of Pennsylvania Health System
- David A. Asch, MD, MBA, executive director, Center for Health Care Innovation, University of Pennsylvania Health System
- Roy Rosin, MBA, chief innovation officer, University of Pennsylvania Health System
- Shivan Mehta, MD, MBA, MSHP, associate chief innovation officer, University of Pennsylvania Health System
- Leaders from presenting teams will be available for interviews at a reception following the pitch session
In November, Penn Medicine’s Innovation Accelerator Program, now in its fifth year, awarded “seed money” to kick start new projects aimed at improving health care delivery and patient outcomes. As part of the Innovation Accelerator Program, which provides financial support to thought leaders across Penn Medicine in their efforts to develop, test, and implement new approaches to health care, the annual pitch session affords teams the opportunity to discuss their project’s progress with health system leadership, and determine plans for growth and success.
Including this year’s projects, the Innovation Accelerator Program has provided more than $2.5 million in funding for inventive projects over the past five years and about twice that in staff support. The 2017 Innovation Accelerator class is co-sponsored by UnitedHealthcare, supporting their priority of enabling high-value care delivery models.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.